LCMS Limited provides customized and innovative analytical solutions, offering state-of-the-art laboratory services and expert analysis to address complex problems. We pride ourselves on delivering personalized attention with fast turnaround times to answer your analytical measurement questions.
With 25 years in business, LCMS Limited is led by its Founder and CEO, Dr. Voyksner, a pioneer in the field with nearly 45 years of experience in LC-MS/MS. Dr. Voyksner was among the first researchers to build and publish on LC-MS/MS using a triple quadrupole (Analytical Letters, 15, 1-12, 1982), demonstrating his foundational impact on the technology.
LCMS Limited has a robust history of successful projects, serving government agencies (FDA, USDA, NIH, EPA), State agencies, and over 300 industrial clients. Our work supports critical research, development, and analysis in pharmaceutical, biomedical, environmental, and forensic sectors.
Dr. Voyksner, an internationally recognized leader in LC/MS/MS, has secured over 300 government grants and commercial contracts. He has authored over 100 articles in peer-reviewed scientific journals and serves as an Adjunct Professor at North Carolina State University’s School of Veterinary Medicine. His leadership extends to organizing five Montreux LC/MS Symposia, serving on the board of the American Society for Mass Spectrometry, and contributing to the editorial board for the Journal of Chromatography.
Work can be performed under a GLP environment.
General:
LC/MS/MS target compound quantification
LC/high resolution MS/MS for compound-impurity- metabolite or degradation product identification
LC/UV analysis and purity determination
LC/fluorescence analysis
ELISA determinations
Bioassay measurements using chemiluminescence or fluorescence probes.
Facility and equipment testing for cross-contamination
Preclinical and early discovery- metabolite ID, PKDM
Detection and identification of impurities and degradation products in formulations or manufactured products
Proteomics: